Australia's most trusted
source of pharma news
Friday, 18 April 2025
Posted 15 April 2025 AM
An update from the March PBAC meeting held a few barbed accusations aimed at pharma companies who were criticised on several fronts - including for being the driving force behind "submission churn".
A stakeholder engagement briefing note from Chair Professor Robyn Ward and her Deputy Jo Watson, did not 'name names' when it came to specific companies but sponsors were clearly in the firing line.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.